Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with ...

Inogen showed strong prospects in the POC (Portable Oxygen Concentrator ... They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...

The company has a market cap of $236.04 million, a price ... high of $13.33. Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to ...

Needham & Company LLC restated their hold rating on shares of Inogen (NASDAQ:INGN – Free Report) in a report released on Wednesday morning,Benzinga reports. Separately, StockNews.com raised Inogen ...

The produces oxygen concentrators for patients suffering ... West It is doubtless a positive to see that the Inogen, Inc. ( NASDAQ:INGN ) share price has gained some 38% in the last ...